Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision metadata on the page changed from v3.6.0 to v3.6.3, indicating a new revision was released. It appears to be a metadata-level update and does not alter the page content or user experience.SummaryDifference0.0%

- Check30 days agoChange DetectedAdds a recruitment status note and new user-help navigation items (How to Read a Study Record, Common Questions, How to Join a Study). Also updates the Intervention header to Intervention/Treatment and adds a Revision: v3.6.0 note, reflecting formatting and version updates rather than substantive trial data.SummaryDifference0.2%

- Check37 days agoChange Detected- Page revision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page.SummaryDifference0.0%

- Check59 days agoChange DetectedVersion update from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation/system rather than a substantive change to study content.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision metadata was updated from v3.5.2 to v3.5.3 on the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.